Home » BRA M: Farma Conde São José Triumphs Over Sada Cruzeiro in a Thrilling Showdown

BRA M: Farma Conde São José Triumphs Over Sada Cruzeiro in a Thrilling Showdown

by WoV

In a nail-biting clash of the undefeated giants in the 2023/24 BET7K Men’s Superliga, Farma Conde São José emerged victorious in a tight contest against Sada Cruzeiro. The intense match concluded with a scoreline of 3-2, favoring São José, who displayed remarkable resilience by coming from behind. The set scores read 25-15, 18-25, 20-25, 25-15, 15-12, marking the tenth and second-to-last round of the season’s first phase.

Photo: Agência i7/Sada Cruzeiro

This victory propels São José to a top position in the Superliga standings, boasting a perfect record of 10 wins from 10 matches, accumulating 28 points. They remain the only undefeated team in the league. On the other side, Sada Cruzeiro, the reigning champions of the Superliga, Copa Brasil, and the South American Championship, find themselves in second place with 27 points. Notably, São José had also edged past Sada Cruzeiro earlier this season in the Supercup, with a similar 3-2 scoreline. The match’s standout performer was São José’s Felipe Roque, who led the scoring with 28 points, earning him the prestigious Viva Volei Trophy.

Both teams suffered notable losses. Douglas Souza of São José had to withdraw post the second set due to knee pain. Sada Cruzeiro’s middle blocker, Lucão, faced a hand injury after a collision with Wallace, and Cledenilson also succumbed to an injury, exiting the court during the tie-break with an ankle issue.

SuperLiga – Round 10

  • Sada Cruzeiro vs. Farma Conde São José 2-3 (15-25, 25-18, 25-20, 15-25, 12-15)
Standings provided by Sofascore

Related Articles

Leave a Comment

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.